Trial description:
Front-Line therapy in CLL: Assessment of Ibrutinib + Rituximab
Contact name:
Dr George Follows
Trial start date:
Monday, January 19, 2015
Trial end date:
Tuesday, February 4, 2020
Trial tumour type:
Haematological
Show on Radiotherapy:
No
